Sclerotherapy in treatment of venous malformations in the maxillofacial region in children
AbstractSclerotherapy firmly holds a leading position in the treatment of malformations, as it is effective, minimally invasive, and in many cases, can be performed on an outpatient basis under local anesthesia.
The advantages of sclerotherapy include minimizing risks and postoperative complications, creating optimal conditions for sclerosing agent-induced regression of pathological venous conglomerates, a short and uneventful postoperative period, and last but not least enabling outpatient treatment. The improved quality of life resulting from the reduction or elimination of pain and the restoration of functional activity of the maxillofacial region positively impacts the patients’ overall somatic and aesthetic state, as well as their mental health.
Keywords: venous malformation; maxillofacial venous malformations; sclerotherapy; bleomycin; lauromacrogol
Funding. The study had no financial support.
Conflict of interest. The authors declare no conflicts of interest.
Authors’ contribution. Study conception and design – Dosmukhamedova D.V., Ergashev B.B.; data collection and handling – Dosmukhamedova D.V.; statistical processing – Kuchkarova R.R.; draft manuscript preparation – Kuchkarova R.R.; manuscript revision – Dosmukhamedova D.V.
For citation: Dosmukhamedova D.V., Ergashev B.B., Kuchkarova R.R. Sclerotherapy in treatment of venous malformations in the maxillofacial region in children. Angiology and Vascular Surgery. Journal named after Academician A.V. Pokrovsky. 2025; 31 (4): 118–25. DOI: https://doi.org/10.33029/1027-6661-2025-31-4-118-125
Dear readers!
Full-text version of the article is available only in paper version.